Real-time index price for TSX Composite Weight Index (TXCE), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

Dec 24 (Reuters) - European shares ended the holiday-shortened trading week near record highs and on track for their strongest annual performance since 2021, supported by easing interest rates, ...

Access to GLP-1 weight loss drugs could improve the long-term health and well-being for millions of Americans.

Asian markets are mostly higher after the U.S. benchmark S&P 500 closed at another record high following a report that the ...

The immediate market response highlighted the significance of the regulatory timeline. Novo Nordisk received clearance to launch its tablet in early January 2026. In contrast, Eli Lilly's drug, ...

Regulators at the U.S. Food and Drug Administration on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.

A pill version of the popular GLP-1 weight-loss drug Wegovy has been green-lit for use in the U.S. Here’s what that means for ...

The yield on 10-year Treasury notes was last up 2.71 basis points (bps) at 4.198%. ​The U.S. dollar curbed its losses against the yen and euro after the U.S. economic growth data, which reinforced ...

Married 32-year-old who piled on pounds by binge-eating charts weight loss journey online, now has better skin, new-found ...

Gold and silver miners are expected to drive the TSX higher today as precious metals reach uncharted levels. Gold Futures ...

Though she “usually [doesn’t] like paparazzi pictures” of herself, she posted a recent one that showed her walking down a sidewalk in Los Angeles.

The Food and Drug Administration on Monday approved a pill version of Wegovy, Novo Nordisk’s blockbuster weight loss drug.